P.J. Schmidt Investment Management (PJS)’s Vertex Pharmaceuticals VRTX Stock Holding History

P.J. Schmidt Investment Management (PJS)’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$530K	Sell	1,066 -931	-47%	-$413K	0.08%	128
2026 Q1	$892K	Sell	1,997 -56	-3%	-$26.1K	0.15%	85
2025 Q4	$931K	Sell	2,053 -15	-0.7%	-$6.46K	0.15%	83
2025 Q3	$810K	Sell	2,068 -14	-0.7%	-$5.85K	0.13%	87
2025 Q2	$927K	Buy	2,082 +150	+8%	+$69.1K	0.16%	82
2025 Q1	$937K	Buy	1,932 +41	+2%	+$19.1K	0.17%	76
2024 Q4	$762K	Sell	1,891 -130	-6%	-$60.3K	0.13%	86
2024 Q3	$940K	Buy	2,021 +183	+10%	+$87.9K	0.16%	80
2024 Q2	$862K	Buy	1,838 +870	+90%	+$378K	0.16%	78
2024 Q1	$405K	Buy	968 +58	+6%	+$24.5K	0.08%	130
2023 Q4	$391K	Buy	910 +135	+17%	+$49.9K	0.08%	129
2023 Q3	$283K	Hold	775	–	–	0.06%	144
2023 Q2	$277K	Sell	775 -160	-17%	-$53.9K	0.06%	143
2023 Q1	$317K	Sell	935 -30	-3%	-$9K	0.07%	142
2022 Q4	$279K	Buy	965 +30	+3%	+$9.14K	0.06%	146
2022 Q3	$281K	Hold	935	–	–	0.07%	147
2022 Q2	$268K	Sell	935 -50	-5%	-$13.4K	0.06%	150
2022 Q1	$269K	Sell	985 -1,301	-57%	-$309K	0.06%	155
2021 Q4	$556K	Sell	2,286 -962	-30%	-$187K	0.11%	116
2021 Q3	$598K	Sell	3,248 -1,338	-29%	-$261K	0.12%	110
2021 Q2	$919K	Sell	4,586 -1,568	-25%	-$328K	0.18%	89
2021 Q1	$1.3M	Buy	6,154 +550	+10%	+$121K	0.27%	69
2020 Q4	$1.28M	Buy	5,604 +1,956	+54%	+$449K	0.29%	66
2020 Q3	$774K	Buy	3,648 +642	+21%	+$177K	0.19%	83
2020 Q2	$873K	Buy	3,006 +143	+5%	+$38.8K	0.26%	63
2020 Q1	$681K	Buy	2,863 +34	+1%	+$7.8K	0.24%	70
2019 Q4	$619K	Sell	2,829 -105	-4%	-$21.3K	0.17%	87
2019 Q3	$497K	Buy	2,934 +736	+33%	+$130K	0.14%	94
2019 Q2	$403K	Buy	+2,198	New	+$384K	0.12%	109

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

P.J. Schmidt Investment Management (PJS)'s VRTX Position: Q2 2026 in Review

P.J. Schmidt Investment Management (PJS) reduced its Vertex Pharmaceuticals (VRTX) stake by 47% in Q2 2026, selling an estimated $413K and leaving 1,066 shares worth $530K. The position accounts for 0.08% of the portfolio, ranked #128.

P.J. Schmidt Investment Management (PJS) first reported a position in VRTX in Q2 2019 and has held it in 29 quarters since. The position peaked at $1.3M in Q1 2021. 1,749 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

P.J. Schmidt Investment Management (PJS) held 1,066 shares of Vertex Pharmaceuticals worth $530K as of Q2 2026.
P.J. Schmidt Investment Management (PJS) sold 931 Vertex Pharmaceuticals shares in Q2 2026, an estimated $413K.
Vertex Pharmaceuticals made up 0.08% of P.J. Schmidt Investment Management (PJS)'s portfolio in Q2 2026, its #128 holding.
P.J. Schmidt Investment Management (PJS) first reported a position in Vertex Pharmaceuticals in Q2 2019 and has held it in 29 quarters since.
P.J. Schmidt Investment Management (PJS)'s Vertex Pharmaceuticals position peaked at $1.3M in Q1 2021.
1,749 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on P.J. Schmidt Investment Management (PJS)'s 13F filing for Q2 2026, filed 29 Jul 2026.